BMJ  2003;326:1196-1198 (31 May), doi:10.1136/bmj.326.7400.1196

Education and debate

How to dance with porcupines: rules and guidelines on doctors' relations with drug companies

Elizabeth Wager, publications consultant1

1 Sideview, Princes Risborough HP27 9DE liz@sideview.demon.co.uk

Interactions between doctors and drug companies can lead to ethical dilemmas. This article gives an overview of the guidance and codes of practice that aim to regulate the relationship

The first 150 words of the full text of this article appear below.

Like the porcupine's quills, drug companies' interactions with doctors are numerous and can be harmful if approached the wrong way. (Lewis and colleagues used the analogy of dancing with porcupines to describe university-industry relations,1 and I liked it so much I have appropriated it.) I have aimed to highlight the major rules and guidelines relating to interactions between doctors and drug companies, but this is not an exhaustive survey.

SUE SHARPLES

Codes of conduct for pharmaceutical companies developed by industry organisations tend to be voluntary but are often backed up by complaints procedures. Many countries with major pharmaceutical sectors have national codes, such as those of the Association of the British Pharmaceutical Industry (ABPI),2 Medicines Australia,3 and the Pharmaceutical Research and Manufacturers of America.4 These usually concentrate on drug companies' marketing activities—most prohibit companies from giving doctors inducements to prescribe their products in the form of payments, lavish gifts, or . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

No more free lunches: How to dance with porcupines
Steven Rudolphy
BMJ 2003 327: 341. [Extract] [Full Text]

This article has been cited by other articles:

  • Jutel, A., Menkes, D. B (2009). "But Doctors do it...": Nurses' Views of Gifts and Information from the Pharmaceutical Industry. The Annals of Pharmacotherapy 43: 1057-1063 [Abstract] [Full text]  
  • Morgan, M A, Dana, J, Loewenstein, G, Zinberg, S, Schulkin, J (2006). Interactions of doctors with the pharmaceutical industry.. J. Med. Ethics 32: 559-563 [Abstract] [Full text]  
  • Blumenthal, D. (2004). Doctors and Drug Companies. NEJM 351: 1885-1890 [Full text]  
  • Rudolphy, S. (2003). No more free lunches: How to dance with porcupines. BMJ 327: 341-341 [Full text]  
  • Abbasi, K., Smith, R. (2003). No more free lunches. BMJ 326: 1155-1156 [Full text]  

Rapid Responses:

Read all Rapid Responses

Guidelines for Physicians
John R Bennett, et al.
bmj.com, 4 Jun 2003 [Full text]
RCP Guidelines
Liz Wager
bmj.com, 23 Jun 2003 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ